BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Pharm Country

  VC Firm OrbiMed Advisors Raises $325 Million For Second Asia Healthcare Fund

  September 10, 2014

   · 

  1 min read
• Deals

  Kolltan Pharmaceuticals Inc. Acquires Xetrios Therapeutics And Exclusive Rights To Salk Institute for Biological Studies Patents Related To The TAM Receptor Tyrosine Kinase Family

  September 10, 2014

   · 

  1 min read
• Biotech Bay

  Pulmonx, Inc.’s Zephyr Endobronchial Valve Demonstrates Statistically And Clinically Significant Results In A Prospective, Randomized Controlled Trial

  September 10, 2014

   · 

  1 min read
• BioMidwest

  Airway Therapeutics, LLC Raises $4.6 Million In Series A Funding

  September 10, 2014

   · 

  3 min read
• Business

  ArtVentive Medical Group, Inc. Announces Addition To European Sales Management Team

  September 10, 2014

   · 

  3 min read
• Drug Development

  Cellceutix Provides Initial Observations Of Completed ABSSSI Phase 2b Trial; Company Submits Investigational New Drug Application To FDA For Phase 2 Trial Of Brilacidin-OM For Oral Mucositis

  September 10, 2014

   · 

  7 min read
• Genetown

  Biogen Idec, Inc. (Massachusetts) Release: New International Survey Finds MS Patients And Neurologists View Communication Positively, Yet Struggle To Discuss Key MS Symptoms

  September 10, 2014

   · 

  1 min read
• Business

  Peregrine Pharmaceuticals, Inc. Reports First Quarter Fiscal Year 2015 Financial Results And Recent Developments

  September 10, 2014

   · 

  17 min read
• Biotech Beach

  Ansun Biopharma Announces Late Breaker Oral Presentation At ICAAC On The Clinical Activity Of Paradase™, An Investigational Drug For The Treatment Of Severe Parainfluenza Infection

  September 10, 2014

   · 

  1 min read
• BioForest

  Bill & Melinda Gates Foundation Commits $50 Million To Support Emergency Response To Ebola

  September 10, 2014

   · 

  2 min read